FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention represents a pharmaceutical composition for treating malignant growths of prostate based on fosfestrola. According to the invention the composition Additionally contains sodium dichloroacetate, wherein the ratio fosfestrola to sodium dihloracetatu ranges from 1:10 to 10:1.
EFFECT: higher efficiency of therapeutic action due to synergetic effect, low toxicity due to low therapeutic doses of each of ingredients of composition.
1 cl, 4 dwg, 11 ex
Title | Year | Author | Number |
---|---|---|---|
PHARAMCEUTICAL COMPOSITION FOR TREATMENT OF ONCOLOGICAL DISEASES | 2012 |
|
RU2484814C1 |
PHARMACEUTICAL COMPOSITION FOR ONCOLOGICAL DISEASES | 2011 |
|
RU2463053C1 |
PHARMACEUTICAL COMPOSITION FOR TREATING MALIGNANT GROWTHS | 2019 |
|
RU2710273C1 |
METHOD FOR PROCESSING TUMOUR CELLS | 2016 |
|
RU2632429C1 |
AGENT FOR TARGETED THERAPY OF MALIGNANT GROWTHS | 2018 |
|
RU2699558C2 |
METHOD FOR PREVENTION OF PULMONARY METASTATIC LESIONS EXPERIMENTALLY | 2013 |
|
RU2546034C1 |
METHOD OF TREATING MELANOMA IN VIVO | 2023 |
|
RU2824428C2 |
STABLE PHARMACEUTICAL COMPOSITION BASED ON ACTINOMYCIN D FOR INJECTIONS | 2014 |
|
RU2587716C2 |
COMBINATIONS OF GROWTH-REGULATING FACTORS AND HORMONES FOR NEOPLASIA TREATMENT | 2003 |
|
RU2321422C2 |
AGENT ELICITING ANTITUMOR EFFECT | 2003 |
|
RU2254139C1 |
Authors
Dates
2016-07-10—Published
2015-06-09—Filed